J9050 HCPCS Level II code: Injection, carmustine, 100 mg
J9050 is the HCPCS code for “Injection, carmustine, 100 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9050Injection, carmustine, 100 mg
Short description: Carmustine injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J9050 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1984
Where J9050 sits
- 1J codesDrugs administered other than orally
- 2Active code J9050Injection, carmustine, 100 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9050 mean?
J9050 is the HCPCS code for “Injection, carmustine, 100 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9050?
CMS lists J9050’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9050
All J codesJ9044Injection, bortezomib, not otherwise specified, 0.1 mgJ9045Injection, carboplatin, 50 mgJ9046Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mgJ9047Injection, carfilzomib, 1 mgJ9048Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mgJ9049Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mgJ9051Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mgJ9052Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mgJ9053Injection, belantamab mafodotin-blmf, 0.1 mgJ9054Injection, bortezomib (boruzu), 0.1 mgJ9055Injection, cetuximab, 10 mgJ9056Injection, bendamustine hydrochloride (vivimusta), 1 mg